# MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer

> **NCT04078269** · PHASE1 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 6 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** Dendritic cell immunotherapy
- **BIOLOGICAL:** Antigen-specific DTH
- **BIOLOGICAL:** Control DTH

## Key facts

- **NCT ID:** NCT04078269
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-26
- **Primary completion:** 2024-02-01
- **Final completion:** 2025-03-03
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04078269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04078269, "MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04078269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*